Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood
about
Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?The anti-inflammatory effects of macrolides.Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharideAnti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease.On-chip evaluation of neutrophil activation and neutrophil-endothelial cell interaction during neutrophil chemotaxis.Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cellsIn vitro effects of ciprofloxacin and roxithromycin on apoptosis of jurkat T lymphocytes.Combination of Erythromycin and Curcumin Alleviates Staphylococcus aureus Induced Osteomyelitis in Rats.The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.Inflammatory cytokine (interleukin 6 and tumour necrosis factor alpha) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide.Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production.Macrolide therapy is associated with reduced mortality in acute respiratory distress syndrome (ARDS) patients.
P2860
Q30327329-03B3132C-D2D9-4199-A388-16034B0F029EQ33714051-D6762DEE-7682-4FB7-A25E-6AE2B846ED9CQ33978028-07CD078B-218D-4017-B1F3-ED8A3071093DQ33983140-D745BE73-67B0-43A7-A502-BBF2E46E6289Q34940688-9542BBD2-47FB-42B7-AA6A-2A305335AFAAQ35609105-D5B69586-7AF3-472F-B605-628B7890748CQ37401755-4AD7FD91-714D-4FAA-8B82-F279CA901D6AQ37722509-D95F0C0E-2681-49D5-ADFE-01ABC33AC37CQ39475847-16411FC4-C943-4019-94D4-04756B351E53Q39732018-C89DCAE7-DA3A-4D03-B6D5-B504FA573B9BQ40061198-B37872DC-72B1-4BE9-827A-63D428BCDF99Q40157277-6388B90A-1CA8-441B-BDA9-6F68B2CEA5EBQ40619272-59AB484E-F68C-479C-952B-482A8D9A10A7Q42066416-C7A31ADB-D52E-4EF3-830C-3024E89C076EQ50072815-07966F42-C55C-4BF7-8D2E-962D305B113C
P2860
Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Erythromycin inhibits tumor ne ...... ccus pneumoniae in whole blood
@en
Erythromycin inhibits tumor ne ...... cus pneumoniae in whole blood.
@nl
type
label
Erythromycin inhibits tumor ne ...... ccus pneumoniae in whole blood
@en
Erythromycin inhibits tumor ne ...... cus pneumoniae in whole blood.
@nl
prefLabel
Erythromycin inhibits tumor ne ...... ccus pneumoniae in whole blood
@en
Erythromycin inhibits tumor ne ...... cus pneumoniae in whole blood.
@nl
P2093
P2860
P1476
Erythromycin inhibits tumor ne ...... ccus pneumoniae in whole blood
@en
P2093
M J Schultz
P Speelman
S J van Deventer
T van der Poll
P2860
P304
P407
P577
1998-07-01T00:00:00Z